We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.22B
AUM Growth
+$53.1M
Cap. Flow
+$124M
Cap. Flow %
2.37%
Top 10 Hldgs %
65.84%
Holding
128
New
6
Increased
35
Reduced
25
Closed
11

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$21.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$15.6M
3
BABA icon
Alibaba
BABA
+$14.5M
4
META icon
Meta Platforms (Facebook)
META
+$11.7M
5
BIDU icon
Baidu
BIDU
+$11.7M

Top Sells

Rank Stock Value
1
AIRM
Air Methods Corp
AIRM
+$5.53M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$4.23M
3
AMGN icon
Amgen
AMGN
+$3.82M
4
CNC icon
Centene
CNC
+$3.52M
5
LDRH
LDR HOLDINGS CORP COM STK
LDRH
+$3.12M

Sector Composition

Rank Sector Weight
1 Financials 26.04%
2 Healthcare 25.69%
3 Communication Services 13.78%
4 Consumer Discretionary 12.54%
5 Consumer Staples 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
101
Medtronic
MDT
$112B
$677K 0.01%
7,800
-10,000
-56% -$809K
ACAD icon
102
Acadia Pharmaceuticals
ACAD
$4.45B
$662K 0.01%
20,390
– –
ZVRA icon
103
Zevra Therapeutics
ZVRA
$559M
$657K 0.01%
10,313
– –
WP
104
DELISTED
Worldpay, Inc.
WP
$645K 0.01%
11,400
– –
OXFD
105
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$634K 0.01%
70,460
– –
LLY icon
106
Eli Lilly
LLY
$1.09T
$560K 0.01%
7,100
– –
XLRN
107
DELISTED
Acceleron Pharma
XLRN
$557K 0.01%
16,400
– –
ICPT
108
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$542K 0.01%
3,800
– –
PTCT icon
109
PTC Therapeutics
PTCT
$6.18B
$447K 0.01%
63,700
– –
BLUE
110
DELISTED
bluebird bio
BLUE
$277K 0.01%
494
+108
+28% +$61.2K
ACOR
111
DELISTED
Acorda Therapeutics
ACOR
$255K ﹤0.01%
83
– –
BAP icon
112
Credicorp
BAP
$30.6B
$216K ﹤0.01%
1,400
+500
+56% +$71.6K
ESPR
113
DELISTED
Esperion Therapeutics
ESPR
$188K ﹤0.01%
19,000
– –
ASXC
114
DELISTED
Asensus Surgical, Inc.
ASXC
$180K ﹤0.01%
11,538
-19,231
-63% -$604K
LUMO
115
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$149K ﹤0.01%
1,471
– –
ASX icon
116
ASE Group
ASX
$70.6B
$141K ﹤0.01%
25,300
-12,500
-33% -$66K
INFI
117
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$54K ﹤0.01%
40,680
– –
ACHC icon
118
Acadia Healthcare
ACHC
$2.63B
– –
-35,000
Closed -$1.93M
CMCSA icon
119
Comcast
CMCSA
$86.8B
– –
-35,780
Closed -$1.09M
CRDF icon
120
Cardiff Oncology
CRDF
$60.7M
– –
-4,564
Closed -$1.53M
DFS
121
DELISTED
Discover Financial Services
DFS
– –
-16,110
Closed -$821K
DHR icon
122
Danaher
DHR
$142B
– –
-13,048
Closed -$831K
EIX icon
123
Edison International
EIX
$30.5B
– –
-26,900
Closed -$1.93M
SCI icon
124
Service Corp International
SCI
$11.7B
– –
-57,200
Closed -$1.41M
TGT icon
125
Target
TGT
$66.4B
– –
-11,200
Closed -$921K
2 3 4
5
6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2016 Portfolio in Review

As of Q2 2016, C WorldWide Group held 128 positions worth $5.22B, up 1% from $5.17B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

C WorldWide Group's Q2 2016 filing shows 6 new, 35 increased, 25 reduced and 11 closed positions. Its largest new stake was Adeptus Health Inc: 50,000 shares worth $2.58M. The largest sale was Air Methods Corp, an estimated $5.53M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q2 2016 buy was Adeptus Health Inc: 50,000 shares worth $2.58M.
  • C WorldWide Group added most to Visa in Q2 2016, an estimated $21.7M increase.
  • C WorldWide Group's biggest Q2 2016 reduction was Air Methods Corp, cutting an estimated $5.53M.
  • C WorldWide Group fully exited Tetraphase Pharmaceuticals, Inc. in Q2 2016, selling an estimated $2.14M.
  • C WorldWide Group's ten largest holdings make up 66% of its $5.22B portfolio in Q2 2016.
  • C WorldWide Group opened 6 new positions and closed 11 in Q2 2016.
  • C WorldWide Group's portfolio value rose 1% quarter-over-quarter to $5.22B.

Based on C WorldWide Group's 13F filing for Q2 2016, filed 29 Jul 2016.